Related Experiment Videos
Development of terfenadine-pseudoephedrine double-layer tablet dissolution-equivalent to core tablet
1College of Pharmacy, Seoul National University, Shinlim-Dong, Kwanak-Ku, South Korea.
Drug Development and Industrial Pharmacy
|May 29, 2000
Summary
A novel double-layer tablet formulation for terfenadine-pseudoephedrine was developed. This new formulation demonstrated dissolution equivalence to the original core tablet across various pH conditions.
Area of Science:
- Pharmaceutical Sciences
- Drug Delivery Systems
- Formulation Development
Background:
- Sustained-release formulations aim to improve drug efficacy and patient compliance.
- Terfenadine-pseudoephedrine combination therapy requires careful control of drug release profiles.
- Developing dissolution-equivalent generic formulations is crucial for therapeutic interchangeability.
Purpose of the Study:
- To design and evaluate a double-layer tablet as a dissolution-equivalent alternative to a terfenadine-pseudoephedrine core tablet.
- To optimize the composition of fast-release and sustained-release layers for bioequivalence.
- To confirm the dissolution profile similarity between the novel double-layer tablet and the core tablet.
Main Methods:
- Formulation of fast-release layer using various disintegrants and polymers.
- Preparation of sustained-release layer with controlled ratios of ethylcellulose and hydroxypropylmethylcellulose (HPMC).
- In vitro dissolution testing at different pH values (1.2, 4.0, 6.8) and analysis of drug release kinetics (Fickian diffusion).
Main Results:
- The optimized fast-release layer contained terfenadine/pseudoephedrine/lactose/cornstarch/sodium bicarbonate/hydroxypropylcellulose (HPC)/sodium lauryl sulfate/microcrystalline cellulose.
- The selected sustained-release layer composed of pseudoephedrine/ethylcellulose/HPMC exhibited comparable pseudoephedrine dissolution to the core tablet's inner layer.
- Dissolved drug amounts from the double-layer and core tablets showed less than 5% deviation, with no significant differences across tested pH levels.
Conclusions:
- The developed double-layer tablet formulation is dissolution-equivalent to the original terfenadine-pseudoephedrine core tablet.
- This formulation offers a viable alternative for achieving sustained drug release and therapeutic equivalence.
- The Fickian diffusion mechanism governs pseudoephedrine release from the sustained-release layer.